Hanne-Charlotte Andersen, RN, MCN
Steno Diabetes Center
Copenhagen, Denmark
Hanne-Charlotte Andersen is a clinical nurse specialist at Steno Diabetes Center in Copenhagen, Denmark. She works in collaboration with Steno Education Center and has been an educator at Practical Diabetology Courses in Denmark and abroad. She worked with Guided Self Determination, a Theory, developed by Vibeke Zoffmann. Hanne-Charlotte Andersen has also developed Insulin Pump Courses with 10 years of experience in insulin pump treatment and sensor. She has also been an educator at national courses on insulin pump training, basal and advanced.
Pratik Choudhary, MBBS, MRCP, MD
King’s College Hospital, Denmark Hill
London, England
Dr. Choudhary's main research work is based around mechanisms and treatments of hypoglycaemia unawareness, with a special interest in the psychology of patients with recurrent hypoglycaemia, and the changes in the brain that are associated with that seen on neuroimaging.
He is also interested in the use of technology in diabetes, with a large clinical and research interest in the use of insulin pumps, continuous glucose monitoring and closed loop insulin delivery. He is also clinical lead for the islet transplant service at King's, and diabetes lead for the pancreas transplantation at Guy's Hospital.
Anders Frid, MD, PHD
Skåne University Hospital, Malmö, Sweden
Dr. Frid was born 12 April 1951. He graduated from Medical School June 1977, and became a Specialist in Internal Medicine January 1985. Dr. Frid wrote his Thesis for the degree of Dr. Med. Sc. (Ph D) March 1992 at Karolinska Institute in Stockholm: Insulin Injection and Absorption. Since October 2001, Dr. Frid has served as senior consultant at Clinic of Endocrinology, University Hospital SUS, Malmö, Sweden. He has been an investigator in over 20 clinical trials, certified in GCP, and has published more than 50 papers mainly in the areas of insulin injection technique, diabetes and pregnancy and diet and diabetes. Currently, Dr. Frid is the Medical supervisor for the Diabetes Nurse education at University of Malmö.
Anette Hougaard, RN
Steno Diabetes Center
Copenhagen, Denmark
Anette Hougaard is a registered diabetes nurse at the Steno Diabetes Center in Copenhagen, Denmark. Anette has been working with diabetes pumps and continuous glucose monitoring since 2005. Anette has also been conducting group sessions on the psycho/social effects of living with type 1 diabetes. Before her career in diabetes, Anette worked within oncology for 15 years.
Emma Jenkins, BSc
Royal Bournemouth General Hospital
Bournemouth, Dorset, United Kingdom
Emma Jenkins qualified in 1989 with an honors degree in Nutrition and Dietetics from Cardiff University and immediately settled to work as a dietitian in Bournemouth, Dorset, UK. In 1994, Ms. Jenkins took on the role of Diabetes Specialist Dietitian working initially on the management and development of education for type 2 diabetes. She then spent a few years supporting research programs on hypoglycemia in type 1 diabetes, including investigating the effects of caffeine and alcohol. From 1999, Emma’s interests moved toward both structured education for type 1 diabetes and insulin pump therapy and she has become the leading dietitian in these areas. Ms. Jenkins assists in the coordination of insulin pump services for adults in Bournemouth and undertakes education and training for patients. For 10 years, Emma has also trained other health professionals in the management of type 1 diabetes and pumps. These training programs have been both locally and nationally based or associated with insulin pump companies.
Donna Jornsay, CPNP, CDE, CDTC
Long Island Jewish Medical Center, New Hyde Park, New York, USA
Donna Jornsay, CPNP, CDE, received her associate’s degree in nursing from the State University of New York at Upstate Medical Center where she went on to receive her certificate as a pediatric nurse practitioner. She completed her bachelor’s degree in nursing at the University of the State of New York in
1983. Donna has worked as a diabetes nurse educator and nurse practitioner for the past 30 years, and has held positions in pediatrics, adult medicine and high risk obstetrics. She has been a clinician in areas of direct patient care, as well as a clinical supervisor of pediatric nurse practitioners. She has also been the clinical coordinator of several university based diabetes and pregnancy programs. Donna has also worked in the diabetes industry, as a clinical scientific liaison for Abbott Diabetes Care, and as a clinical nurse specialist for Medtronic Diabetes. In these roles, she gained research and development experience, sales experience, and patient training and management experience with continuous glucose monitoring and insulin pump therapy. Currently, Donna works as a diabetes clinical specialist at Long Island Jewish Medical Center where she is responsible for inpatient diabetes education, staff development, and quality improvements in the care of patients with diabetes.
David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Health Services, San Mateo, California, USA
University of California, San Francisco
San Francisco, California, USA
Dr. David Klonoff founded the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Health Services to facilitate development of new devices and drugs for people with diabetes. He is also a Clinical Professor of Medicine at the University of California, San Francisco (UCSF). Dr. Klonoff’s body of work includes 160 publications, 2 patents, and 86 clinical trials as principal investigator.
Dr. Klonoff chaired the scientific advisory board for developing the first FDA-approved insulin patch pump and participated in development of the first FDA-approved dedicated diabetes telemedicine system, the first FDA-approved inhaled insulin, and the first three FDA-approved incretin drugs for diabetes. He is currently the lead investigator for the first-ever randomized controlled multicenter trial of the world’s first artificial pancreas product for outpatient use. Dr. Klonoff has chaired or served on 34 government grant review panels related to diabetes technology, including panels for the National Institutes of Health, the Centers for Disease Control and Prevention, NASA, National Science Foundation, U.S. Army, JDRF, and the University of Michigan.
Dr. Klonoff is a graduate of the University of California, Berkeley, where he was elected to Phi Beta Kappa in his junior year, and UCSF Medical School, where he was elected to Alpha Omega Alpha in his junior year. His postgraduate training included 2 years at University of California, Los Angeles Hospital and 3 years at UCSF hospitals. He has been practicing endocrinology in Burlingame and has been a member of the medical staff of Mills-Peninsula Health Services since 1981.
Dr. Klonoff has served as a civilian medical officer for the U.S. Army’s Telemedicine & Advanced Technology Research Center (TATRC) for biosensors and physiologic monitoring, and chaired the CDC’s initiative, “Sticking with Safety,” for safe blood glucose monitoring to avoid transmitting blood-borne viruses. He also led technical and clinical guideline panels about continuous glucose monitoring for Clinical and Laboratory Standards Institute and The Endocrine Society. In 2010, Dr. Klonoff received an FDA Director’s Special Citation Award for outstanding contributions related to diabetes technology. He is the only diabetes expert to receive this award. In 2011, Dr. Klonoff was cited as being in the top 1% of endocrinologists nationwide by US News & World Report in collaboration with Castle Connolly Medical Ltd. Dr. Klonoff received the 2012 Gold Medal Oration and Distinguished Scientist Award from the Dr. Mohan’s Diabetes Specialties Centre and Madras Diabetes Research Foundation of Chennai, India, which is the world’s largest diabetes clinic.
Priv.-Doz. Dr. Markus Laimer
University Hospital of Bern, Bern, Switzerland
Fields of research:
Type 1 diabetes, Type 2 diabetes, Obesity
Education:
Medical University Innsbruck
Dissertation:
The effects of Tacrolimus versus Cyclosporin A on glucose and lipid metabolism after liver transplantation
Career History:
2001 - 2003 Postdoc, Research Laboratory for Metabolic Diseases, Department of Internal Medicine, Clinical Division of General Internal Medicine, Medical University Innsbruck, Austria
2002 - 2008 Assistant doctor, Department of Internal Medicine, Clinical Division of General Internal Medicine, Medical University Innsbruck, Austria
Since July 2008 Internist
19.10.2009 Postdoctoral lecture qualification (Verleihung der Venia docendi im Habilitationsfach Innere Medizin)
1.12.2009–31.3.2010 Maternity leave (daughter)
Since April 2010 Consultant Department of Medicine I, Medical University Innsbruck, Austria
Since 2010 Emergency physician
Since December 2012 Senior physician, ward and outpatient clinic
Since October 2014 University Hospital Bern, Switzerland
Kirsten Nørgaard, MD, DMSc
Hvidovre University Hospital, Department of Endocrinology
Dr. Kirsten Nørgaard is responsible for type 1 treatment and insulin pump treatment at Hvidovre University Hospital. She is also the leader of the hospital’s outpatient diabetes clinic. Dr. Nørgaard provides education for patients as well as health care professionals on diabetes in general and on insulin pump treatment and CGM use, both at the national and international level. She also participates in curriculum design at the local and national level. Dr. Nørgaard has been involved in insulin pumps since the 1980s and was the author of a nationwide study on the use of CSII in Denmark in 2001, which actually was the start for changing insulin pump use in Denmark. She also participated in more multicenter studies in Europe on the use of CSII and CGM, and is a member on different European Advisory Boards for CSII. She has published approx. 70 papers in scientific journals. In 2008, Dr. Nørgaard together with John Bagterp Jørgensen from Danish Technical University established the DiaCon-collaboration for developing closed loop and other technical support solutions for diabetes treatment. Recently, results of the first study of in-patient closed-loop at Hvidovre Hospital were published.
Eva Palik, MD, PhD
London Medical, London, United Kingdom
After graduating from the Semmelweis University, Budapest in 1993 Dr. Palik started working at the 3rd Department of Internal Medicine of the University. She obtained her certificate in Internal Medicine in 1999. After completing specialisation in Internal Medicine she started working with patients with various metabolic diseases, most importantly obese people, people with various and people with diabetes. She has experience with both type 1 and type 2 diabetes, and also with some other, less common diabetes types (pancreas diseases, MIDD, steroid induced diabetes). She is familiar with the latest therapeutic options including insulin pump therapy and CGM. In 2013 she participated in the European Diabetes Technology Course. She is a co-author of a Hungarian diabetes blog “Édes szívem” (“Sweetheart”). From 2010 she works as leading physician at Saneidos Zrt, a company developing a web-based health assessment and counselling tool, part funded by the European Union. The company received additional funding to develop a health assessment and management tool for young people aged 14-25.
Form the 31st of March, 2014 she is working at London Medical in London as Consultant in Diabetes and Internal Medicine. Here, among other responsibilities she is responsible for coordinating patient education and designing courses for a variety of patients.
Martin Ridderstråle, MD, MBA
Steno Diabetes Center A/S
Copenhagen, Denmark
Martin Ridderstråle is Head of Clinic and Vice President of Steno Diabetes Center located in Gentofte, outside Copenhagen, Denmark, since 2013. He was previously Head of the Department of Endocrinology at Skåne University Hospital in nearby Malmö and Lund, Sweden, for six years. He is a specialist in Internal Medicine, and Endocrinology and Diabetology, and has an MBA from Copenhagen Business School, Denmark. In his capacity as a manager he is focusing on combining lean and agile processes to achieve value-based health care delivery chains. He is a firm proponent of a consistent emphasis on common standards to reach common goals, with daily visualisation of deviations and goals to drive continuous improvements. Martin Ridderstråle also holds a position as adjunct professor of Endocrinology at Lund University Diabetes Center. His research is devoted to diagnostics, treatment and care of obesity-driven diabetes and the effective use of diabetes technology. He has 67 peer reviewed publication including Nature, Science, Lancet, Nature Genetics, PLoS Medicine, Diabetes, American Journal of Clinical Nutrition, Diabetologia, and Obesity.
Jens Sandahl Christiansen, MD, FRCPI, DrMedSci
Aarhus University Hospital
Aarhus, Denmark
Jens Sandahl Christiansen is a professor at the University of Aarhus, and a consultant in the Department of Medicine (endocrinology), Aarhus University Hospital. He is the chairman of the district board for organizing diabetes care and is involved in the national board for the evaluation of efforts being made by health care professionals within type 2 diabetes.
Dr. Christiansen earned his MD at University of Copenhagen School of Medicine. He was a house officer at Steno Memorial Hospital, and has worked as registrar, senior registrar, and consultant at medical departments (endocrinology) at the Copenhagen County Hospital and at the University Hospital in Aarhus. He has held a number of academic appointments at the University of Aarhus since 1989 and is currently a Professor of Medicine. He is chairman of the GCP Unit of Aarhus University Hospital.
His clinical and research interests are growth hormone (GH) physiology and consequences of GH deficiency as well as diabetic kidney disease, continuous glucose monitoring, and insulin absorption. He has conducted numerous studies and is actively involved in many clinical research projects in the field of endocrinology. Jens Sandahl Christiansen is the co-author on more than 600 publications.
He is currently Editor-in-Chief of Endocrine Connections, member of the European Association for the Study of Diabetes, the U.S. Endocrine Society, the European Society for Pediatric Endocrinology and immediate-past-president of the Growth Hormone Research Society. He was the first treasurer of the European Society of Endocrinology (2006–09).
Dr. Christiansen has lectured extensively on topics such as pathogenesis of diabetes, optimal treatment of diabetes, complications of diabetes, the metabolic syndrome, diabetes in adolescents, diabetes in pregnancy, organizing diabetes treatment, as well as on all aspects of growth hormone replacement therapy.
Dr. Christiansen has been awarded The Dandy Prize, The Hanstedgaard Prize, The Clinical Endocrinology Trust Medal and The Minkowski Medal, and elected Honorary Member of The Polish Society of Endocrinology.
Jane Seley, DNP, MPH, MSN, BC-ADM, CDE
New York Presbyterian/ Weill Cornell Medical Center
New York, New York, USA
Dr. Seley is a diabetes nurse practitioner in the Division of Endocrinology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City. She is an adjunct lecturer at the Hunter-Bellevue School of Nursing and serves as a preceptor for both Hunter and New York University’s Adult Nurse Practitioner Programs in New York City.
Dr. Seley is a contributing editor and column coordinator for the American Journal of Nursing. She has published extensively in nursing and diabetes journals on the topics of diabetes care and management. She has served on numerous advisory and review boards and is a frequent presenter at diabetes and general conferences and events.
Dr. Seley is a past-chair of the American Diabetes Association’s professional council on education and past course director for the annual scientific sessions and postgraduate courses. She is a member of the American Association of Diabetes Educators Board of Directors, a fellow in the New York Academy of Medicine, and serves on the editorial boards of Journal of Diabetes Science and Technology, Practical Diabetology, and Diabetes Health.
Astrid Tombek, Dipl. Oec. troph/ DB DDG
Diabetes Centre in Bad Mergentheim
Bad Mergentheim, Germany
Astrid Tombek is currently a Chief Diabetes Trainer at Diabetes Zentrum Bad Mergentheim. She studied Ökotrophologie (Nutritional Science) at TU München-Weihenstephan in Germany. She has been an Educator in Nutrition and Diabetes since 1997 and has been a lecturer in Food Management at the Duale Hochshule since 2007. She has also been a Diabetes Advisor in Germany since 2003.
Donna Tomky, MSN, RN, C-NP, CDE, FAADE
ABQ Health Partners, Albuquerque, New Mexico, USA
Donna Tomky is a Board Certified Adult Nurse Practitioner, Certified Diabetes Educator working for ABQ Health Partners in the Department of Endocrinology and Diabetes, Albuquerque, New Mexico. She has over 25 years experience in diabetes education and clinical management with a special interest in intensive insulin therapy and innovative technologies. She has published extensively on diabetes care and education. She served as President of the American Association of Diabetes Educators in 2011. Other professional activities for AADE include Treasurer, Board of Directors, Outcomes Task Force and member of AADE’s Outcomes Project Team, AADE Research, AADE Fellow and Nominating Committees and served on AADE and ADA’s Task Force for the 2012 National Standards for Diabetes Self-Management Education and Support. She is a Fellow of the American Association of Diabetes Educators and is AADE’s 2013 recipient of the Allene Van Son Distinguished Service Award.
Robert A. Vigersky, MD
Walter Reed National Military Medical Center
Bethesda, Maryland, USA
In 1970, Dr. Vigersky graduated as valedictorian of the pioneering 6-year Program in Liberal Arts and Medicine of Boston University, where he was elected to Phi Beta Kappa and Alpha Omega Alpha. He did his internship and residency in Internal Medicine at The Johns Hopkins Hospital and then completed a 3-year Fellowship in Endocrinology at the National Institutes of Health. He is board certified in both Internal Medicine and Endocrinology and Metabolism.
Dr. Vigersky worked at Walter Reed Army Medical Center until 1984. He then entered private practice and became the President of the Endocrine and Diabetes Group of Washington. He was the Medical Director of the Diabetes Treatment Center at Georgetown University Hospital and the Washington Hospital Center and was voted one of the Washingtonian Magazine’s Top Doctors in 1991, 1993, 1995, 1997 and 1999.
In 2000, Dr. Vigersky re-entered the Army and established the Diabetes Institute of the Walter Reed Health Care System of which he is the Medical Director. He is a Professor of Medicine at the Uniformed Services University of the Health Sciences. He has received numerous military awards, has served in Iraq, Korea, and Germany, and represents the Department of Defense on the Advisory Council of the National Institute of Diabetes and Digestive and Kidney Diseases.
He is an active participant in The Endocrine Society where he served as its President from 2009–2010. He is known as the “father” of The Endocrine Society’s Clinical Practice Guideline program, which has published 25 evidence-based guidelines in endocrinology since 2005.
He has also been active in the Diabetes Technology Society and is a recipient of its 2011 Leadership Award. He chaired both the 2012 International Clinical Diabetes Technology Meeting and the 2012 International Hospital Diabetes Technology Meeting.
Dr. Vigersky is a leading researcher and sought-after speaker on the use of technology and decision-support systems to improve outcomes for patients with diabetes. He has published 123 scholarly papers and 110 abstracts in his specialty.
Melanie Weiss, DNS
Royal Bournemouth General Hospital
Bournemouth, Dorset, United Kingdom
I am currently working as a Diabetes Specialist Nurse at Bournemouth Hospital, Dorset, UK and have been in this post since 2008.
I have been working in Diabetes since 1996. I spent 12 years as a Diabetes Research Nurse supporting many research programmes. These included insulin clamp studies and studying the effect of caffeine and alcohol on hypoglycaemia and cognitive function. Research also included new technology devices including insulin pumps and continuous glucose monitoring systems.
I am currently involved in structured education for type 1 diabetes and also insulin pump therapy for patients and health care professionals. I have been involved in training programmes which are nationally recognised and I am the lead Diabetes Nurse for our Ante natal sevice.
I work part time, married with 3 children age 18, 17 and 14.
